Peer-reviewedLicence not statedCell Research
Ironing out a metabolic barrier to durable CAR T cell therapy
- 1Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, VIC Australia
- 2Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, VIC Australia
Related
- Case Report: Durable, well-tolerated complete response to epcoritamab plus pirtobrutinib in Richter transformation relapsing after CD19 CAR T-cell therapy.
- Adult ADHD, PARK2 copy number variations and the blood-brain barrier: Culture duration-dependent metabolic alterations in human induced pluripotent stem cell-derived in vitro models
- Psychedelic therapy without durable effects: A review and re-evaluation of controlled studies between 1965 and 1977
- Comprehensive Genomic Profiling of Relapsed Interdigitating Dendritic Cell Sarcoma Reveals Novel Molecular Insights in a Patient Achieving Durable Remission After Autologous Stem Cell Transplantation
- Nationwide Evolution of Durable Left Ventricular Assist Device Outcomes Following Introduction of the HeartMate 3 and Destination Therapy in Japan ― The Third Official Report From J-MACS ―
BibTeX
@article{slaney2026ironing,
title = {{Ironing out a metabolic barrier to durable CAR T cell therapy}},
author = {Clare Y. Slaney and Rachel Xu and Phillip K. Darcy},
journal = {Cell Research},
year = {2026},
month = jul,
doi = {10.1038/s41422-026-01282-0},
url = {https://doi.org/10.1038/s41422-026-01282-0},
}
RIS
TY - JOUR
TI - Ironing out a metabolic barrier to durable CAR T cell therapy
AU - Clare Y. Slaney
AU - Rachel Xu
AU - Phillip K. Darcy
PY - 2026
DA - 2026/07/30
JO - Cell Research
DO - 10.1038/s41422-026-01282-0
UR - https://doi.org/10.1038/s41422-026-01282-0
SN - 1001-0602
SN - 1748-7838
ER -